glp-1 agonist benefits Frontiers GLP-1 Drugs & What They
Description
Nevertheless, current evidence supports GLP-1 RAs and multi-agonist formulations as highly promising pharmacotherapies that address the complex, multifactorial pathophysiology of MASLD while simultaneously improving cardiometabolic comorbidities, positioning them as cornerstone treatments in the evolving therapeutic landscape for this prevalent and burdensome disease
Lehrke M, Marx N, Patel S, et al
2020;71 doi: 10.1016/j.nut.2019.110615
2015;36:e00285
It was also revealed in another study that GLP-1 had more effect on OPG than RANKL in mRNA and protein level of the isolated Wistar rat tibiae (9)
